| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4261855 | Transplantation Proceedings | 2006 | 4 Pages |
Abstract
IR-induced pulmonary dysfunction is caused by increased vascular resistance and increased perfusion pressure. These changes are, at least in part, due to the ongoing release of TxA2. Administration of 8Br-cGMP protected against TxA2-induced vasoconstriction.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
M. SÅupski, K. Szadujkis-Szadurska, R. Szadujkis-Szadurski, L. Szadujkis-Szadurski, Z. WÅodarczyk, J. Andruszkiewicz, A.T. Sinjab,